Home
 > News
print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST

The National Institute for Health and Care Excellence (NICE) published two clinical guidelines about electrochemotherapy

07/04/2013


Tell your friend  | 

In March 2013, the National Institute for Health and Care Excellence (NICE) have issued two interventional procedure guidelines on electrochemotherapy treatment and care of people with specific tumours. The first NICE interventional procedure guidance gives recommendations on electrochemotherapy treatment for patients with metastases in the skin from tumours of non-skin origin and melanoma. For details on this guidance see here.

The second one provides recommendations on electrochemotherapy treatment for patients with primary basal cell carcinoma and primary squamous cell carcinoma tumours. For details on this guidance see here.

These two clinical guidelines are based on the best available evidence and will help healthcare professionals in deciding about appropriate care for specific clinical circumstances. Currently, two additional NICE guidelines on electrochemotherapy treatment are in preparation.


Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: